Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

“Artificial Intelligence” for Pharmacovigilance: Ready for Prime Time?
Robert Ball, Gerald J. Dal Pan
Drug Safety (2022) Vol. 45, Iss. 5, pp. 429-438
Open Access | Times Cited: 51

Showing 26-50 of 51 citing articles:

An open-source platform integrating emerging data sources to support multi-modal active pharmacovigilance
Vlasios K. Dimitriadis, Stella Dimitsaki, Achilleas Chytas, et al.
Frontiers in Drug Safety and Regulation (2023) Vol. 2
Open Access | Times Cited: 6
Drug safety in Africa: a review of systems and resources for pharmacovigilance
Helen Byomire Ndagije, David Walusimbi, Joanita Atuhaire, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 10, pp. 891-895
Open Access | Times Cited: 5
Appeal for Increasing the Impact of Pharmacovigilance
A. Kant
Drug Safety (2023) Vol. 47, Iss. 2, pp. 113-116
Open Access | Times Cited: 5
Explainable Artificial Intelligence for Patient Safety: A Review of Application in Pharmacovigilance
Seunghee Lee, Seonyoung Kim, Jieun Lee, et al.
IEEE Access (2023) Vol. 11, pp. 50830-50840
Open Access | Times Cited: 4
Navigating a transforming landscape: the evolving role of pharmacovigilance physicians in drug development and implications for future challenges and training requirements
Tarek A. Hammad, Salman Afsar, Hervé Le-Louët, et al.
Frontiers in Drug Safety and Regulation (2023) Vol. 3
Open Access | Times Cited: 4
Introduction to Drug Safety and Pharmacovigilance
Jimmy José, Anthony R. Cox, Andrew Bate
Springer eBooks (2024), pp. 3-30
Closed Access | Times Cited: 1
Causality Assessment in Pharmacovigilance
Madhan Ramesh, Anand Harugeri
Springer eBooks (2024), pp. 191-207
Closed Access | Times Cited: 1
Artificial Intelligence and Big Data for Pharmacovigilance and Patient Safety
Muhammad Aasim Shamim, Muhammad Aaqib Shamim, Pankaj Arora, et al.
Journal of Medicine Surgery and Public Health (2024), pp. 100139-100139
Open Access | Times Cited: 1
Beyond boundaries: exploring the transformative power of AI in pharmaceuticals
Gurparsad Singh Suri, Gurleen Kaur, Dheeraj Shinde
Discover Artificial Intelligence (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Pharmacovigilance Through Phased Clinical Trials, Post-Marketing Surveillance and Ongoing Life Cycle Safety
Ananya Chakraborty, J Vijay Venkatraman
(2023), pp. 427-442
Closed Access | Times Cited: 3
Editorial: Computational methods and systems to support decision making in pharmacovigilance
Taxiarchis Botsis, Robert Ball, G. Niklas Norén
Frontiers in Drug Safety and Regulation (2023) Vol. 3
Open Access | Times Cited: 2
A Science-Based Methodology Framework for the Assessment of Combination Safety Risks in Clinical Trials
Andriani C. Patera, Julie Maidment, Brijesh Maroj, et al.
Pharmaceutical Medicine (2023) Vol. 37, Iss. 3, pp. 183-202
Open Access | Times Cited: 2
Back to the Future: The Evolution of Pharmacovigilance in the Age of Digital Healthcare
Michael A. Ibara, Rachel Richesson
Computers in health care (2023), pp. 455-471
Closed Access | Times Cited: 2
Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making
Yoong Khean Khoo, John C. W. Lim, Wei Chuen Tan‐Koi, et al.
Drug Safety (2023) Vol. 47, Iss. 3, pp. 217-225
Closed Access | Times Cited: 2
Bidirectional Encoder Representations from Transformers-like large language models in patient safety and pharmacovigilance: A comprehensive assessment of causal inference implications
Xingqiao Wang, Xiaowei Xu, Zhichao Liu, et al.
Experimental Biology and Medicine (2023)
Open Access | Times Cited: 2
ARTIFICIAL INTELLIGENCE FOR PATIENT SAFETY IN PHARMACOVIGILANCE

International Research Journal of Modernization in Engineering Technology and Science (2024)
Open Access
Can We Ask ChatGPT About Drug Safety? Appropriateness of ChatGPT Responses to Questions About Drug Use and Adverse Reactions Received by Pharmacovigilance Centers
Alexandre Pariente, Francesco Salvo, Virginie Brès, et al.
Drug Safety (2024) Vol. 47, Iss. 9, pp. 921-923
Closed Access
Advanced Applications of Artificial Intelligence in Pharmacovigilance: Current Trends and Future Perspectives
Yogesh S. Ahire, Jayesh H Patil, Harshita N Chordiya, et al.
Journal of Pharmaceutical Research (2024) Vol. 23, Iss. 1, pp. 23-33
Open Access
Innovations in Pharmacovigilance: Leveraging Artificial Intelligence for Enhanced Drug Safety Monitoring
Abdulaziz Ali Al Amri, Ahmed Ebrahem Al Thobaiti, Fahad Sultan Al Zahrani, et al.
Journal of Advances and Scholarly Researches in Allied Education (2024) Vol. 21, Iss. 5, pp. 195-201
Open Access
Safeguarding Patients in the AI Era: Ethics at the Forefront of Pharmacovigilance
Ashish S. Jain, Maribel Salas, Omar Aimer, et al.
Drug Safety (2024)
Closed Access
Artificial intelligence: A regulatory perspective
Francisco Branco, João Sousa
Elsevier eBooks (2024), pp. 43-81
Closed Access
Governance of artificial intelligence and machine learning in pharmacovigilance: what works today and what more is needed?
Michael Gläser, Rory Littlebury
Therapeutic Advances in Drug Safety (2024) Vol. 15
Open Access
Editorial: AI/ML in pharmacovigilance and pharmacoepidemiology
Wen Zou, Pantelis Natsiavas, Assaf Gottlieb
Frontiers in Drug Safety and Regulation (2024) Vol. 4
Open Access
Validation of a Natural Language Machine Learning Model for Safety Literature Surveillance
Jiyoon Park, Malek Djelassi, Daniel Chima, et al.
Drug Safety (2023) Vol. 47, Iss. 1, pp. 71-80
Closed Access | Times Cited: 1
Exploring opportunities for AI supported medication error categorization: A brief report in human machine collaboration
Allan Fong, Christopher Bonk, Varvara Vasilchenko, et al.
Frontiers in Drug Safety and Regulation (2022) Vol. 2
Open Access | Times Cited: 1

Scroll to top